Novo Nordisk A/S ADR (NVO)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NYSE]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Results
download Want to compare other data? Select Fields| Symbol | NVO | JNJ | LLY | PFE | ABBV |
| Company | Novo Nordisk A/S ADR | Johnson & Johnson | Eli Lilly and Company | Pfizer Inc | Abbvie Inc |
| Price Information | |||||
| Exchange | NYSE | NYSE | NYSE | NYSE | NYSE |
| Open | 123.30 | 144.98 | 749.42 | 25.35 | 164.96 |
| High | 124.10 | 145.65 | 752.20 | 25.46 | 167.44 |
| Low | 122.55 | 143.13 | 745.69 | 25.28 | 164.43 |
| Last | 123.27 | 144.64 | 747.87 | 25.32 | 166.16 |
| Change | -1.26 | -0.13 | -2.90 | -0.10 | +1.91 |
| % Change | -1.01% | -0.09% | -0.39% | -0.39% | +1.16% |
| Volume | 1,313,287 | 2,800,350 | 495,614 | 8,337,064 | 1,439,551 |
| 20-Day Average Volume | 3,508,465 | 7,107,017 | 2,290,788 | 34,310,516 | 5,063,950 |
| Previous Close | 124.53 | 144.77 | 750.77 | 25.42 | 164.25 |
| Industry | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma | Large Cap Pharma |
| Has Options | Yes | Yes | Yes | Yes | Yes |
| Technicals | |||||
| 20-Day Moving Average | 126.34 | 152.26 | 765.14 | 26.78 | 172.35 |
| 20-Day Raw Stochastic | 17.13% | 12.55% | 11.90% | 3.67% | 31.66% |
| 20-Day Relative Strength | 47.01% | 27.59% | 48.81% | 32.45% | 42.62% |
| Weighted Alpha | +47.26 | -13.13 | +86.97 | -36.98 | +7.49 |
| Today's Opinion | 56% Buy | 88% Sell | 56% Buy | 100% Sell | 40% Buy |
| Previous Opinion | 56% Buy | 88% Sell | 56% Buy | 100% Sell | 24% Buy |
| Last Month's Opinion | 100% Buy | 16% Sell | 100% Buy | 64% Sell | 100% Buy |
| Performance | |||||
| 5-Days | |||||
| %Chg | -1.61% since 04/11/24 | -2.45% since 04/11/24 | -1.39% since 04/11/24 | -3.70% since 04/11/24 | -0.27% since 04/11/24 |
| Low | 121.79 on 04/16/24 | 143.13 on 04/18/24 | 743.00 on 04/16/24 | 25.26 on 04/17/24 | 160.00 on 04/12/24 |
| High | 127.06 on 04/12/24 | 149.49 on 04/15/24 | 771.83 on 04/17/24 | 26.32 on 04/12/24 | 167.44 on 04/18/24 |
| 1-Month | |||||
| %Chg | -7.16% since 03/18/24 | -7.41% since 03/18/24 | -1.79% since 03/18/24 | -8.50% since 03/18/24 | -6.40% since 03/18/24 |
| Low | 121.79 on 04/16/24 | 143.13 on 04/18/24 | 743.00 on 04/16/24 | 25.26 on 04/17/24 | 160.00 on 04/12/24 |
| High | 132.21 on 03/19/24 | 159.14 on 03/28/24 | 793.67 on 03/28/24 | 28.12 on 03/28/24 | 182.30 on 03/28/24 |
| 3-Month | |||||
| %Chg | +14.72% since 01/18/24 | -9.97% since 01/18/24 | +20.16% since 01/18/24 | -9.70% since 01/18/24 | +2.30% since 01/18/24 |
| Low | 103.38 on 01/23/24 | 143.13 on 04/18/24 | 614.82 on 01/23/24 | 25.26 on 04/17/24 | 160.00 on 04/12/24 |
| High | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 800.78 on 03/04/24 | 28.77 on 01/24/24 | 182.89 on 03/12/24 |
| 6-Month | |||||
| %Chg | +22.68% since 10/18/23 | -4.97% since 10/18/23 | +23.35% since 10/18/23 | -19.25% since 10/18/23 | +11.91% since 10/18/23 |
| Low | 92.94 on 10/27/23 | 143.13 on 04/18/24 | 547.61 on 10/31/23 | 25.26 on 04/17/24 | 135.85 on 11/09/23 |
| High | 138.28 on 03/07/24 | 163.58 on 01/22/24 | 800.78 on 03/04/24 | 31.50 on 10/19/23 | 182.89 on 03/12/24 |
| Key Statistics | |||||
| Market Capitalization, $K | 558,832,384 | 348,864,288 | 713,354,624 | 143,941,824 | 290,828,768 |
| Shares Outstanding, K | 4,487,532 | 2,409,783 | 950,164 | 5,662,542 | 1,770,647 |
| Annual Sales | 33,724,300,000 | 85,159,000,000 | 34,124,100,000 | 58,496,000,000 | 54,318,000,000 |
| Annual Net Income | 12,150,770,000 | 35,153,000,000 | 5,240,400,000 | 2,119,000,000 | 4,863,000,000 |
| Last Quarter Sales | 9,526,160,000 | 13,532,000,000 | 9,353,400,000 | 14,248,000,000 | 14,301,000,000 |
| Last Quarter Net Income | 3,175,360,000 | 4,049,000,000 | 2,189,700,000 | -3,369,000,000 | 822,000,000 |
| 60-Month Beta | 0.41 | 0.53 | 0.34 | 0.61 | 0.58 |
| Per-Share Information | |||||
| Most Recent Earnings | 0.71 on 01/31/24 | 2.71 on 04/16/24 | 2.49 on 02/06/24 | 0.10 on 01/30/24 | 2.79 on 02/02/24 |
| Latest Earnings Date | 05/02/24 | 04/16/24 | 04/30/24 | 05/01/24 | 04/26/24 |
| Most Recent Dividend | 0.663 on 03/22/24 | 1.190 on 02/16/24 | 1.300 on 02/14/24 | 0.420 on 01/25/24 | 1.550 on 04/12/24 |
| Next Ex-Dividends Date | 03/22/24 | 05/20/24 | 02/14/24 | 01/25/24 | 04/12/24 |
| Ratios | |||||
| Price/Earnings ttm | 45.64 | 13.81 | 118.16 | 14.04 | 14.63 |